The Patent Finder

Leadiant Biosciences Limited

Also on record
Records under this name other than the patents Leadiant Biosciences Limited holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 1 patents it holds.

Showing 1 to 10 of 10 · Back to Leadiant Biosciences Limited

PatentTitleStatus Expires Confidence
US 8,071,741Stable recombinant adenosine deaminase
Formerly held
In force
 · From the USPTO record
In forceFrom the USPTO record
US 8,741,283Adenosine deaminase anticancer therapy
Formerly held
In force
 · From the USPTO record
In forceFrom the USPTO record
US 10,391,154Compositions and Methods for Treating or Ameliorating Fibrosis, Systemic Sclerosis and Scleroderma
Formerly held
In force
 · High confidence
In forceHigh confidence
US 7,333,894Methods for the diagnosis of hemodialysis patients and utilization of such methods to improve the administration of intravenous levocarnitine treatments to hemodialysis patients
Term ended
Term ended Nov 26, 2024 · From the USPTO record
Term endedTerm ended Nov 26, 2024From the USPTO record
US 7,011,977Quantification of carnitine levels in dialysis patients
Term ended
Term ended Oct 3, 2019 · From the USPTO record
Term endedTerm ended Oct 3, 2019From the USPTO record
US 6,406,713Methods of preparing low-toxicity drug-lipid complexes
Term ended
Term ended Jun 18, 2019 · From the USPTO record
Term endedTerm ended Jun 18, 2019From the USPTO record
US 4,973,465Microcrystals comprising an active substance having an affinity for phospholipids, and at least one phospholipid, process of preparation
Term ended
Term ended no later than Nov 27, 2010 · Low confidence
Term endedTerm ended no later than Nov 27, 2010Low confidence
US 5,100,591Process for preparing lipid microparticles
Term ended
Term ended no later than Mar 31, 2012 · Low confidence
Term endedTerm ended no later than Mar 31, 2012Low confidence
US 5,616,334Low toxicity drug-lipid systems
Term ended
Term ended no later than Apr 1, 2017 · Low confidence
Term endedTerm ended no later than Apr 1, 2017Low confidence
US 5,728,560Method of treating CD4+ T cell lymphopenia in immuno-compromised patients
Term ended
Term ended no later than Mar 17, 2018 · Low confidence
Term endedTerm ended no later than Mar 17, 2018Low confidence
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 17, 2026 · includes USPTO assignment data published Nov 16, 2026, status data published Nov 17, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited